Etrolizumab Biosimilar - Research Grade
Product Specifications
Background
Uses the same sequence as the therapeutic antibody Etrolizumab
Specifications
Detects human ITGA4/ITGB7
Species Reactivity
Human
Target
ITGA4 + ITGB7
Applications
Functional Assays
Purification Method
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Concentration
5mg/mL
Endotoxin
<1EU/mg Determined by LAL gel clotting assay
Purity
≥95% monomer by analytical SEC, >95% by SDS Page
Buffer
ICH3002
Shipping Conditions
Blue ice
Storage Conditions
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Product Datasheet
https://ichor.bio/productpdf/print/index/url_key/etrolizumab-biosimilar-research-grade/
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Applications Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MMP17, CT (MMP17, MT4MMP, Matrix metalloproteinase-17, Membrane-type matrix metalloproteinase 4, Membrane-type-4 matrix metalloproteinase) (PE)
MMP17, CT (MMP17, MT4MMP, Matrix metalloproteinase-17, Membrane-type matrix metalloproteinase 4, Membrane-type-4 matrix metalloproteinase) (PE)